Skip to content

Clinical trials

Phase 4 Anxiety Disorders trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Anxiety Disorders Phase: Phase 4 Country / region: China Clear all

14 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20143
20193
20212
20221
20231
20251
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Unknown status6
Completed5
Recruiting2
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Second Affiliated Hospital of Wenzhou Medical University3
Xijing Hospital of Digestive Diseases2
Chinese PLA General Hospital1
Chongqing Medical University1
Duke Kunshan University1
Eye & ENT Hospital of Fudan University1
Peking Union Medical College Hospital1
Peking University First Hospital1
Shanghai Mental Health Center1
Si Tianmei1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Anxiety Disorders14
Major Depressive Disorder2
Acute Pain1
Agnosia1
Delirium1
Depressive Disorder1
Emergence Delirium1
Hyperalgesia1
Hypertension1
Mental Disorders1

Trials

Showing 1 to 14 of 14. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.